DXC
DXC Technology Company
DXC trails on the overall score without a compensating advantage in the available component scores.
MSFT
Microsoft Corporation
MSFT has the edge over DXC overall, supported by stronger valuation and stronger fundamentals.
DXC Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Stable | |
| Healthy |
DXC's balance sheet is currently healthy, and its revenue, profitability and cash flow are stable.
MSFT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Healthy | |
| Strong |
MSFT's revenue, profitability, cash flow and balance sheet are all currently healthy.
DXC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 5.7x | $14.85 | — |
| Cheap | 6.9x | $4.77 | -68% |
| Fair | 12x | $8.59 | -42% |
| Current | 22x | $14.85 | — |
| Expensive | 47x | $32.15 | +117% |
Historical ranges are pointers, not guarantees.
DXC's PE is in its fair range at 22x. On analysts' estimates for next year's earnings, today's price would be 5.7x, in its cheap range.
MSFT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 25x | $523 | — |
| Cheap | 27x | $525 | +0.4% |
| Current | 27x | $523 | — |
| Fair | 34x | $652 | +25% |
| Expensive | 37x | $711 | +36% |
Historical ranges are pointers, not guarantees.
MSFT has the edge over DXC in the historical PE scenario, which offers more potential upside but is not a forecast.
DXC Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Stable | |
| Stable | |
| Stable | |
| Limited | |
| Moderate |
Analysts expect DXC's earnings, revenue and profitability to hold roughly steady.
MSFT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Stable | |
| Moderate | |
| High |
MSFT has the edge over DXC on the outlook, with more favorable earnings and revenue expectations.
DXC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.58 | +274% |
| Q3 2026 | $0.69 | -66% |
| Q2 2026 | $0.74 | -64% |
| Q1 2026 | $0.10 | -95% |
| Q4 2025 | $2.32 | +$2.65 |
| Q3 2025 | $2.02 | +1088% |
| Q2 2025 | $2.05 | +377% |
| Q1 2025 | $2.10 | +357% |
| Q4 2024 | -$0.33 | +$1.48 |
DXC's earnings per share have fallen from their peak: $0.69 over the past year, against $3.03 in late 2022.
MSFT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $20.79 | +8.6% |
| Q3 2026 | $19.15 | +36% |
| Q2 2026 | $17.95 | +32% |
| Q1 2026 | $16.80 | +30% |
| Q4 2025 | $15.99 | +29% |
| Q3 2025 | $14.06 | +16% |
| Q2 2025 | $13.64 | +16% |
| Q1 2025 | $12.93 | +12% |
| Q4 2024 | $12.41 | +12% |
MSFT has the edge over DXC on earnings, with more consistent year-over-year improvement.
DXC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3B | -4% |
| Q2 2026 | $3B | -5.1% |
| Q1 2026 | $3.1B | -1.2% |
| Q4 2025 | $3.2B | -1% |
| Q3 2025 | $3.2B | -2.5% |
| Q2 2025 | $3.2B | -2.4% |
| Q1 2025 | $3.2B | -6.4% |
| Q4 2024 | $3.2B | -5.1% |
DXC's revenue fell from its 2019 peak and has held roughly level since: $3B last quarter, down 4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 6.2% | -1.9 points |
| Q2 2026 | 5% | -1.8 points |
| Q1 2026 | 7.6% | +0.3 points |
| Q4 2025 | 8.2% | -0.6 points |
| Q3 2025 | 8% | -0.6 points |
| Q2 2025 | 6.8% | 0 points |
| Q1 2025 | 7.3% | -1.1 points |
| Q4 2024 | 8.9% | +1.3 points |
DXC's operating margin was 6.2% last quarter, down 1.9 points from the same quarter a year ago, near the bottom of its range since 2019.
MSFT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $92.3B | +19% |
| Q2 2026 | $90B | +18% |
| Q1 2026 | $82.9B | +18% |
| Q4 2025 | $81.3B | +17% |
| Q3 2025 | $77.7B | +18% |
| Q2 2025 | $76.4B | +18% |
| Q1 2025 | $70.1B | +13% |
| Q4 2024 | $69.6B | +12% |
MSFT has the edge over DXC on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 50% | +0.9 points |
| Q2 2026 | 45% | +0.2 points |
| Q1 2026 | 46% | +0.7 points |
| Q4 2025 | 47% | +1.6 points |
| Q3 2025 | 49% | +2.3 points |
| Q2 2025 | 45% | +1.8 points |
| Q1 2025 | 46% | +1.1 points |
| Q4 2024 | 45% | +1.9 points |
MSFT has the edge over DXC on profitability, with a higher operating margin.
DXC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $143M | -61% |
| Q2 2026 | $359M | +151% |
| Q1 2026 | $169M | -29% |
| Q4 2025 | $359M | -37% |
| Q3 2025 | $365M | +137% |
| Q2 2025 | $143M | -25% |
| Q1 2025 | $238M | -1.7% |
| Q4 2024 | $568M | -15% |
DXC generated $1B in free cash flow over the past year, down 22% from the year before.
MSFT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $18.6B | -27% |
| Q2 2026 | $19.6B | -23% |
| Q1 2026 | $15.8B | -22% |
| Q4 2025 | $5.9B | -9.3% |
| Q3 2025 | $25.7B | +33% |
| Q2 2025 | $25.6B | +9.6% |
| Q1 2025 | $20.3B | -3.2% |
| Q4 2024 | $6.5B | -29% |
MSFT has the edge over DXC on cash flow, with stronger typical year-over-year growth.
DXC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.6% | -4.3M shares |
| 1 year | -9.6% | -17.2M shares |
| 3 years | -20% | -41.1M shares |
| 5 years | -36% | -90.4M shares |
| Available history | -37% | -94.1M shares |
DXC has the edge over MSFT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $61M |
| Q2 2026 | $71M |
| Q1 2026 | $61M |
| Q4 2025 | $64M |
| Q3 2025 | $76M |
| Q2 2025 | $48M |
| Q1 2025 | — |
| Q4 2024 | $12M |
DXC spent $257M buying back its own shares over the past year, up 89% from the year before.
MSFT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -7M shares |
| 1 year | -0.3% | -20M shares |
| 3 years | -0.2% | -16M shares |
| 5 years | -1.6% | -121M shares |
| Available history | -3.2% | -245M shares |
MSFT has 7.4B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $4.4B |
| Q2 2026 | $4.6B |
| Q1 2026 | $4.6B |
| Q4 2025 | $7.4B |
| Q3 2025 | $5.7B |
| Q2 2025 | $4.5B |
| Q1 2025 | $4.8B |
| Q4 2024 | $5B |
MSFT spent $21B buying back its own shares over the past year, up 5.2% from the year before.
DXC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.8x | Very low |
| Q1 2026 | 0.9x | Very low |
| Q4 2025 | 0.9x | Very low |
| Q3 2025 | 0.9x | Very low |
| Q2 2025 | 1.0x | Very low |
| Q1 2025 | 0.9x | Very low |
| Q4 2024 | 0.9x | Very low |
DXC's net debt is less than a year of its operating earnings (EBITDA).
MSFT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | 0.1x | Very low |
MSFT has the edge over DXC on leverage, with a lower net debt burden relative to earnings.
DXC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 64.6 | Neutral |
| Stochastic | 76.3 | Neutral |
DXC's weekly RSI is 65 (neutral) and its Stochastic is 76 (neutral).
MSFT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 62.1 | Neutral |
| Stochastic | 68.0 | Neutral |
MSFT's weekly RSI is 62 (neutral) and its Stochastic is 68 (neutral).
DXC PE vs Technology Sector
| Metric | DXC | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 28x | 23% below |
| PE % | 63 | 35 | 28 pts above |
DXC has the edge over MSFT on valuation relative to its sector.
MSFT PE vs Technology Sector
| Metric | MSFT | Sector median | Relative |
|---|---|---|---|
| PE | 27x | 28x | 2% below |
| PE % | 16 | 35 | 19 pts below |
MSFT is trading at 27x earnings, in line with the Technology sector's median of 28x.
DXC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.6 | 9.4% above |
| 20 week MA | $11.8 | 26% above |
| 50 week MA | $12.1 | 22% above |
| 100 week MA | $14.0 | 6.1% above |
| 200 week MA | $18.1 | 18% below |
DXC has bounced recently, but its long-term trend is still down: it's above its 8-, 20-, 50- and 100-week averages, but 18% below its 200-week average.
MSFT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $524.7 | 0.3% below |
| 20 week MA | $484.8 | 7.9% above |
| 50 week MA | $446.9 | 17% above |
| 100 week MA | $453.8 | 15% above |
| 200 week MA | $411.5 | 27% above |
MSFT's trend is up, with a small recent dip: it's below only its 8-week average, and 27% above its 200-week average.
DXC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $36.7 | $22.9 | -38% |
| 2021 | $22.9 | $32.6 | +42% |
| 2022 | $32.6 | $26.5 | -19% |
| 2023 | $26.5 | $22.9 | -14% |
| 2024 | $22.9 | $20.2 | -12% |
| 2025 | $20.2 | $15.1 | -25% |
| 2026 YTD | $15.1 | $14.9 | -1.7% |
DXC has finished four years in a row lower, and it's down 1.7% so far in 2026.
MSFT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $159.0 | $222.8 | +40% |
| 2021 | $222.8 | $334.7 | +50% |
| 2022 | $334.7 | $238.7 | -29% |
| 2023 | $238.7 | $376.0 | +58% |
| 2024 | $376.0 | $430.5 | +14% |
| 2025 | $430.5 | $487.7 | +13% |
| 2026 YTD | $487.7 | $523.0 | +7.2% |
MSFT has the edge over DXC on returns for 2026, with the stronger performance.